Case number 1:21-cv-01619
Eagle Pharmaceuticals, Inc. et al v. Hospira, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 20, 2022 | 25 | Stipulation of Dismissal with prejudice (3) |
| Apr 20, 2022 | 25 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 11,103,483 B2. (Attachments: # (1) Stipulation of Dismissal with prejudice)(kmd) |
| Apr 19, 2022 | 24 | Stipulation of Dismissal (3) Docket Text: STIPULATION of Dismissal with prejudice by Eagle Pharmaceuticals, Inc.. (Silver, Daniel) |
| Apr 19, 2022 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per [24] Stipulation of Dismissal with prejudice. (kmd) |
| Apr 7, 2022 | 23 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Alan Richard Silverstein on behalf of Hospira, Inc. (Silverstein, Alan) |
| Apr 6, 2022 | 22 | Order (2) Docket Text: ORDER that the scheduled set by the Court in C.A. No. 21-1256-CFC shall apply with modifications as outlined in the Order re [20] Letter. Signed by Judge Colm F. Connolly on 4/6/2022. (nmf) |
| Mar 4, 2022 | 21 | Notice of Substitution of Counsel (2) Docket Text: NOTICE OF SUBSTITUTION OF COUNSEL re Eagle Pharmaceuticals, Inc.: Entry of appearance of attorney Daniel M. Silver. Attorney John W. Shaw, Karen E. Keller, and Nathan Hoeschen terminated. (Silver, Daniel) |
| Feb 15, 2022 | 20 | Exhibit B (3) |
| Feb 15, 2022 | 20 | Exhibit A (4) |
| Feb 15, 2022 | 20 | Main Document (6) Docket Text: Letter to The Honorable Colm F. Connolly from Nathan R. Hoeschen regarding Proposed Scheduling Orders. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Hoeschen, Nathan) |
| Feb 15, 2022 | 19 | SO ORDERED (2) Docket Text: SO ORDERED, re [18] STIPULATION TO EXTEND TIME for the parties to submit a proposed scheduling order to February 15, 2022, filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Re-Setting Deadlines: Notice of Compliance deadline set for 2/15/2022. Signed by Judge Colm F. Connolly on 2/15/2022. (kmd) |
| Feb 14, 2022 | 18 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a proposed scheduling order to February 15, 2022 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Feb 10, 2022 | 17 | SO ORDERED (2) Docket Text: SO ORDERED, re [16] STIPULATION TO EXTEND TIME to Submit a Proposed Scheduling Order to February 14, 2022, filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Notice of Compliance deadline re-set for 2/14/2022. Signed by Judge Colm F. Connolly on 2/10/2022. (kmd) |
| Feb 9, 2022 | 16 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Submit a Proposed Scheduling Order to February 14, 2022 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Jan 10, 2022 | 15 | Order (1) Docket Text: ORDER: IT IS ORDERED that, on or before February 10, 2022, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 2/10/2022.) Signed by Judge Colm F. Connolly on 1/10/2022. (nmf) |
| Jan 5, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [13] MOTION for Pro Hac Vice Appearance of Attorney Jennifer Koh, Daniel G. Brown, Kenneth G. Schuler, Marc N. Zubick and Alex Grabowski filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 1/5/2022. (nmf) |
| Jan 5, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Daniel G. Brown, Alex M. Grabowski, Jennifer Koh, Kenneth G. Schuler, and Marc N. Zubick for Eagle Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
| Jan 5, 2022 | 14 | Answer to Counterclaim (7) Docket Text: ANSWER to [8] Answer to Complaint, Counterclaim by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Jan 4, 2022 | 13 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jennifer Koh, Daniel G. Brown, Kenneth G. Schuler, Marc N. Zubick and Alex Grabowski - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Jan 3, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [12] STIPULATION TO EXTEND TIME [and Proposed Order] for Plaintiffs to move, plead, or otherwise respond to Defendant's counterclaims (D.I. 8) to January 5, 2022 filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Reset Answer Deadlines: Cephalon, Inc. answer due 1/5/2022; Eagle Pharmaceuticals, Inc. answer due 1/5/2022; Teva Pharmaceuticals International GmbH answer due 1/5/2022. Ordered by Judge Colm F. Connolly on 1/3/2022. (kmd) |
| Dec 28, 2021 | 12 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME [and Proposed Order] for Plaintiffs to move, plead, or otherwise respond to Defendant's counterclaims (D.I. 8) to January 5, 2022 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Dec 21, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [11] MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Adam D. Harber, Elise M. Baumgarten, Shaun P. Mahaffy and Ben Picozzi of Williams & Connolly LLP to represent Plaintiffs Teva Pharmaceuticals International GmbH and Cephalon, Inc, filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Ordered by Judge Colm F. Connolly on 12/21/2021. (kmd) |
| Dec 21, 2021 | 11 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Adam D. Harber, Elise M. Baumgarten, Shaun P. Mahaffy and Ben Picozzi of Williams & Connolly LLP to represent Plaintiffs Teva Pharmaceuticals International GmbH and Cephalon, Inc - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Dec 13, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Ren-How Harn for Hospira, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Dec 10, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] MOTION for Pro Hac Vice Appearance of Attorney Sara T. Horton, Michael W. Johnson, Ren-How Harn, and Melanie L. Lee, filed by Hospira, Inc. Ordered by Judge Colm F. Connolly on 12/10/2021. (kmd) |
| Dec 10, 2021 | 9 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Hospira, Inc.. (Connolly, Arthur) |
| Dec 10, 2021 | 10 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Sara T. Horton, Michael W. Johnson, Ren-How Harn, and Melanie L. Lee - filed by Hospira, Inc.. (Connolly, Arthur) |
| Dec 8, 2021 | 8 | Answer to Complaint (18) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, COUNTERCLAIM against Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH by Hospira, Inc..(Connolly, Arthur) |
| Nov 24, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Nov 18, 2021 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Eagle Pharmaceuticals, Inc., Cephalon, Inc., Teva Pharmaceuticals International GmbH. Hospira, Inc. served on 11/17/2021, answer due 12/8/2021. (Keller, Karen) |
| Nov 16, 2021 | 1 | Main Document (13) Docket Text: COMPLAINT filed against Hospira, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3744054.) - filed by Eagle Pharmaceuticals, Inc., Cephalon, Inc., Teva Pharmaceuticals International GmbH. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(apk) |
| Nov 16, 2021 | 6 | Summons Issued (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Hospira, Inc. on 11/16/2021. (apk) |
| Nov 16, 2021 | 5 | 7.1 Disclosure (Cephalon, Inc.) (1) |
| Nov 16, 2021 | 5 | 7.1 Disclosure (Eagle Pharmaceuticals, Inc.) (1) |
| Nov 16, 2021 | 5 | Main Document (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Janus Henderson Group PLC, Corporate Parent BlackRock Institutional Trust Company, N.A. for Eagle Pharmaceuticals, Inc.; Corporate Parent Teva Pharmaceutical Industries Ltd. for Cephalon, Inc., Teva Pharmaceuticals International GmbH filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Attachments: # (1) 7.1 Disclosure (Eagle Pharmaceuticals, Inc.), # (2) 7.1 Disclosure (Cephalon, Inc.)(apk) |
| Nov 16, 2021 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 11,103,483 B2. (apk) |
| Nov 16, 2021 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A Date of Expiration of Patent: 01/28/2031. (apk) |
| Nov 16, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) |
| Nov 16, 2021 | 1 | Civil Cover Sheet (2) |
| Nov 16, 2021 | 1 | Exhibit A (13) |
| Nov 16, 2021 | 1 | Complaint* (1) |
